MedTrace Logo

Soybean Oil Trial of cArdiovascular Risk

NCT02404207 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2016-05-12

No results posted yet for this study

Summary

The study will determine the effects of different types of soybean oils on biomarkers of risk for cardiovascular disease and diabetes. There will be four 4-week diet periods in which participants will consume the following oils, within the context of a controlled diet: soybean oil, high-oleic soybean oil, blend of high oleic soybean oil \& fully hydrogenated soybean oil, and blend of palm olein \& palm stearin.

Conditions

Interventions

OTHER

Soybean oil

Participants will be fed soybean oil as part of a controlled (typical American) diet.

OTHER

High-oleic soybean oil

Participants will be fed high-oleic soybean oil as part of a controlled (typical American) diet.

OTHER

High-oleic soybean oil + fully hydrogenated soybean oil

Participants will be fed a blend of high-oleic soybean oil and fully hydrogenated soybean oil as part of a controlled (typical American) diet.

OTHER

Palm olein + palm stearin

Participants will be fed a blend of palm olein + palm stearin as part of a controlled (typical American) diet.

Sponsors & Collaborators

  • USDA Beltsville Human Nutrition Research Center

    lead FED

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
CROSSOVER

Eligibility

Min Age
30 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-03-31
Primary Completion
2015-10-31
Completion
2015-10-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02404207 on ClinicalTrials.gov